Tentative Program
conferenceseries.comCancer Diagnostics 2017Tentative ProgramOncologist & Diagnostics ConferenceAugust 28- 30,2017 Brussels, e speaker ancerdiagnostics.conferenceseries.com/
conferenceseries.comCancer Diagnostics 2017Program at A GlanceDay 108.00-09.00TimeGeneral Session09.00-09.15Inaugural AddressKeynote/Plenary Talk 109.15-09.45Least of 3 Keynote/PlenaryKeynote/Plenary Talk 209.45-10.15TalksKeynote/Plenary Talk 310.15-10.45Panel Discussions/Group PhotoCoffee/Tea Break 10.45-11.00 (Networking)11.00-12.405 speaker (20 mins each)13.30-15.3015.45-17.25Lunch Break 12.40-13.306 Speakers (20 Mins Each)Speaker slots are availableCoffee/Tea Break 15.30-15.45 (Networking)5 Speakers (20 Mins Each)19 speaker for day 1Evening SessionsMorning on 15 Speakers (20 Mins Each)13.25-15.05Coffee/Tea Break 10.40-10.55 (Networking)5 Speakers (20 Mins Each)Keynote speaker slots are availableLunch Break 12.35-13.255 Speakers (20 Mins Each)15.20-17.00Coffee/Tea Break 15.05-15.20 (Networking)5 Speakers (20 Mins Each)10.55-12.35Session 25 Speakers (20 Mins Each)5 Speakers (20 Mins Each)5 Speakers (20 Mins Each)40 speaker for day 2Evening Sessions Morning SessionsDay 25 Speakers (20 Mins Each)Time09.00-10.4010.55-12.3513.25-15.05Session 15 Speakers (20 Mins Each)Coffee/Tea Break 10.40-10.55 (Networking)5 Speakers (20 Mins Each)Keynote speaker slots are availableLunch Break 12.35-13.255 Speakers (20 Mins Each)Session 25 Speakers (20 Mins Each)5 Speakers (20 Mins Each)5 Speakers (20 Mins Each)Coffee/Tea Break 15.05-15.20 (Networking)15.20-17.005 Speakers (20 Mins Each)5 Speakers (20 Mins Each)Awards and Closing CeremonyNOTE: Program Schedule is subject to change with final allotment of the speaker slotsSpeaker slots are available for Cancer Diagnostics 40 speaker for day 3Evening SessionsMorning SessionsDay 3
conferenceseries.comCancer Diagnostics 2017Conference Highlights Types of Cancer Cancer Diagnostics Types Types of Oncology Cancer Screening Tests Carcinoma Approaches in CancerTherapy Cancer Treatment andTherapies Cancer Biomarkers Cancer Immunotherapy Radiology and Imaging inCancer Recent DiagnosticsTechnologies Genomic Biomarkers inCancer Cancer Biopsy Nanotechnology in Cancer Haemato-Oncology Psycho oncology Geriatric Oncology Alternative medicine Cancer Diagnostics Market Neurological Cancer Pathophysiology of Cancer Pancreatic and ColorectalCancer Cancer Innovations Oncology Nursing Cancer Cell Biology Oncologists Meet Entrepreneurship MeetFor detailed sessions, please visit: it your abstract online at: ract-submission.phpRegister online: ies.com/
conferenceseries.comGlimpses of Cancer Diagnostics Cancer Diagnostics 2017
conferenceseries.comGlimpses of Cancer Diagnostics Cancer Diagnostics 2017
conferenceseries.comCancer Diagnostics 2017Plan your Trip to om/
Plan your Trip to Belgium
conferenceseries.comScientific ProgramCancer Diagnostics Conference & ExpoJune 13-15, 2016Hosting Organization: Conference Series LLCRome, Italy2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: 1-702-508-5200 Ext: 8047, Toll free: 1-800-216-6499e-mail: cancerdiagnostics@cancersummit.org; cancerdiagnostics@insightconferences.com
Scientific ProgramDay 1June 13, ning CeremonyKeynote ForumIntroductionTitle: Sensitivity and Specificity of the Empirical Lymphocyte Genome Sensitivity (LGS) Assay:Implications for Improving Cancer DiagnosticsDiana Anderson, University of Bradford, UKTitle: Optimal Breast Cancer Pathology 2016Tibor Tot, Centarl Hospital Falun, SwedenGroup PhotoNetworking & Refreshments Break@ FoyerTrack 1: Cancer Diagnostics MarketTrack 2: Cancer Diagnostics TypesSession IntroductionSession Chair: Diana Anderson, University of Bradford, UKSession Co-Chair: Tibor Tot, Central Hospital Falun, SwedenTitle: Fast Evaluation of Biopsy for Prostate Cancer Diagnosis by Fraunhofer IKTSAndreas Lehmann, Fraunhofer Institute for Ceramic Technologies and Systems IKTS, GermanyTitle: How to develop a cancer diagnostic device for the POC settingJuan Roman, Cambridge Consultants, UKTitle: Engineering design process and comparison of multi wavelength real time auto-fluorescence andfluorescence imaging guide system irradiance with xenon lamps and light-emitting diodes (LEDs) foropen and laparoscopic cancer surgeryHyun Soo lim, Chungnam National University, South KoreaTitle: Development of female vaginal fluid collection device for the endometrial cancer preliminary studyJhih-Yan Cheng, National Tsing Hua University, TaiwanLunch Break @ RestaurantTrack 7: Predictive Cancer BiomarkersTrack 9: Cancer TreatmentSession IntroductionSession Chair: Diana Anderson, University of Bradford, UKSession Co-Chair: Tibor Tot, Central Hospital Falun, SwedenTitle: The role of pancreatic stellate cells in pancreatic disordersOleg V Gerasimenko, Cardiff University, UKTitle: Differences of signalling pathways and miRNA expression in colon and breast carcinoma cell lineson hipoxic conditionHafize Seda Vatansever, Celal Bayar University, TurkeyTitle: The role of Epo/EpoR signaling pathway in colorectal cancerRenata Dobrila Dintinjana, Clinical Hospital Center Rijeka, CroatiaTitle:Fertility sparing surgery in early stages of cervical cancerAleksandar Stefanović, President M.D. Ph. D UGOSCGRS, BelgradeTitle: Fertility sparing in young patients with early stages of endometrial cancerKatarina Jeremic, University of Belgrade School of Medicine, SerbiaNetworking & Refreshments Break@ Foyer
Title: Anticancer activities of religiously important plants from IndiaRachana, Jaypee Institue of Information Technology, IndiaTitle: Prostatic tissue levels of chemical elements as cancer markersVladimir Zaichick, Medical Radiological Research Center, RussiaSpecial SessionTitle: Breast Cancer HeterogenityTibor Tot, Central Hospital Falun, SwedenTitle: General Overview of the Comet assayDiana Anderson, University of Bradford, UKDay 2June 14, 2016Olimpica-4Keynote TalkTitle: The UHRF1 expression in serum and tissue for gastric cancer detectionFeng Yan, Nanjing Medical University and Jiangsu Cancer Hospital, ChinaTrack 3: Cancer Screening TestsTrack 6: Approaches in Cancer TherapyTrack 8: Cancer Genomics and EpigeneticsTrack 10: Recent Diagnostics TechnologiesSession IntroductionSession Chair: Feng yan, Nanjing Medical University and Jiangsu Cancer Hospital, ChinaSession Co-Chair: Senqing Chen, Nanjing Medical University and Jiangsu Cancer Hospital, ChinaTitle: Serum biomarkers and ovarian cancer risk: Utility for early detection and preventionDayan Goodenowe, President, Phenomenome Discoveries Inc., CanadaTitle: Molecular basis of hereditary colorectal cancer and current research statusChen Senqing, Jiangsu Institute of Cancer Research, ChinaNetworking & Refreshments Break@ FoyerTitle: The mechanisms of asparaginase-induced pancreatitisJulia V Gerasimenko, Cardiff University, UKTitle: Tumor-derived exosomes in cancer progression and treatment failureShaorong Yu, Jiangsu Institute of Cancer Research, ChinaTitle: Mast cells inhibition as therapeutic approach on mammary cancerAna I Faustino-Rocha, University of Trás-os-Montes and Alto Douro, PortugalPoster PresentationsCDE001Title: Prognostic significance of N-glycolyl GM3 ganglioside expression in non-small celllung carcinoma patients: New evidencesAdriana Carr Perez, Center of Molecular Immunology, CubaCDE002Title: A functional approach for searching biomarkers of gliomaKopylov Alexey, Lomonosov Moscow State University, RussiaCDE003Title: Molecular study of synthesis of protoporphyrin IX in fluoropositive and fluoronegativecell cultures of human glioblastomaPavlova Galina, Institute of Gene Biology-RAS, RussiaCDE004Title: Renal cell carcinoma in kidney transplant candidatesKonstantinos A Zorbas, Temple University Hospital, USACDE005Title: Frequent ID4 gene promoter hypermethylation in breast cancerYan Zhang, Jiangsu Cancer Hospital, ChinaCDE006Title: Asymmetrical asymptomatic tonsilsJoseph Colclough, Northwick Park Hospital, UKCDE007Title: New ruthenium phthalocyanines in modulation of nitric oxide and singlet oxygenrelease: Physical chemical characterizations and improvement of cytotoxicity withliposomes against cancer cellsRamos L.C.B, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, BrazilCDE008Title: The role of FABP9 in prostate cancerMajed Al Fayi, Liverpool University, UKCDE009Title: Experimental treatment of prostate cancer by suppressing the biological activity of FABP5Waseem Al-Jameel, University of Liverpool, UKCDE010Title: Improving Breast Cancer diagnosis by circulating microRNAsJulia Alejandra Pezuk, Instituto Sirio-Libanes de Ensino e Pesquisa – Hospital Sirio-Libanes- Sao Pablo, Brazil
Lunch Break@ RestaurantTitle: Comparison of the MRI sequences in ideal fiducial marker-based radiotherapy for prostate cancerOsamu Tanaka, Gifu Municipal Hospital, JapanTitle: Monitoring cancer progression by detecting circulating cancer cells with both epithelial andmesenchymal featuresYong-Jie Lu, Queen Mary University of London, London, UKTitle: The status of medicinal plants and herbal drugs in prevention and treatment of cancerMajid Asadi-Samani, Shahrekord University of Medical Sciences, IranTitle: Probable non-papillomavirus etiology of warty carcinoma of the uterine cervixDimitrova B, Medical University Pleven, BulgariaTitle: The possible involvement of Epstein–Barr virus in the etiology of leukemia in Sudanese patientsHaitham Eltigani Mohammed Elawad, Omdurman Islamic University, SudanNetworking & Refreshments Break@ FoyerTitle: Combination Therapy against NGcGM3 ganglioside and EGFR: A new approach for lung cancertreatment.Adriana Carr Perez, Center of Molecular Immunology,CubaTitle: Evaluation of the SYT-SSX2 fusion gene transcript in synovial sarcoma cells and microvesicles as apotential biomarker for synovial sarcomaFricke Alba, University of Freiburg, GermanyPanel DiscussionsAward & Closing CeremonyDay 3Conference Series2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USAPh: 1-888-843-8169Fax: ce Series5716 Corsa Ave., Suite 110, WestlakeLos Angeles, CA 91362-7354, USAPh: 1-650-268-9744Fax: 1-650-618-1414america@conferenceseries.comJune 15, 2016Networking and Lunch @ @ RestaurantConference SeriesSEZ Unit, Building No. 20, 9th FloorAPIIC Layout, HiTec CityHyderabad-500081, Telangana, INDIAPh: 040-40131823, 040-47482222asia@conferenceseries.comToll freeUSA & Canada: 1-800-216-6499Australia: 1-800-651-097Europe: 0805-080048
Hosting Organization: Conference Series LLC 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: 1-702-508-5200 Ext: 8047, Toll free: 1-800-216-6499 e-mail: cancerdiagnostics@c
1. Phase 2 CAP Waiver Required Package Documents: a. DD Form 2905 (see an example on the next slide) b. AAC Denial Letter and Tentative Selection Letter c. Tentative Selectee Resume d. Position Description, JobAnno
What is a Parcel Map/Tract Map? The Parcel Map or Tract Map is the instrument that actually divides the property. A Parcel Map or Tract Map must conform to and incorporate all of the Tentative Parcel or Tract Map conditions and must also comply with the standards for Parcel Maps or Tract Maps
Tentative Conference Program: Solutions in Seattle, April 16-18, 2015 Symposium on ADR in the Courts: Judges and Mediation This interactive session will explore ethical, justice, and pract
Euro Heart Failure 2020 Tentative Program June 18-19, 2020 Paris, France 31st European Heart and Heart Failure Congress Conference Series LLC Ltd 47 Churchfield Road, London, W36AY, UK, Pho
RESEARCH QUESTIONS Definitions of hypothesis “It is a tentative prediction about the nature of the relationship between two or more variables.” “A hypothesis can be defined as a tentative explanation of the research problem, a possible outcome of the research, or an educated guess about the research outcome.” (Sarantakos, 1993: 1991)
have a general idea of what the passage is about and what to expect. Strategy 2: Creating a Tentative Summary After you’ve finished your flyover of the passage, take a few seconds and compose a tentative mental summary of what you’ve just read. Try to sort out the details you picked up on and arrange them into a
UPDATED 6/24/15 UNIVERSITY INTERSCHOLASTIC LEAGUE page 1 of 9 UIL Capital Conference, June 29-30, 2015 University of Texas at Austin AT&T Conference Center and Hotel TENTATIVE SCHEDULE: This schedule is tentative. It is provided to let coaches and administrators know approximately what subjects will be covered.
CHETTINAD HARI SHREE VIDYALAYAM Tentative Academic Year Plan 2019-20 Class VI Subject Month Topic English Language June Kinds of sentences Nouns - Kinds, Number, Gender Informal Letter Writing July Pronouns Adjectives & Order of Adjectives August Degrees of Comparison Narrative Writing Simple Tenses Unseen Comprehension - 1
